NAMENDA XR Trademark

Trademark Overview

On Monday, June 4, 2012, a trademark application was filed for NAMENDA XR with the United States Patent and Trademark Office. The USPTO has given the NAMENDA XR trademark a serial number of 85642435. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 16, 2024. This trademark is owned by MERZ PHARMA GmbH & CO. KGaA. The NAMENDA XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cerebral and neurologic disorders, diseases and conditions
namenda xr

General Information

Serial Number85642435
Word MarkNAMENDA XR
Filing DateMonday, June 4, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 16, 2024
Registration Number4415656
Registration DateTuesday, October 8, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cerebral and neurologic disorders, diseases and conditions
Disclaimer with Predetermined Text"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 13, 2012
Primary Code005
First Use Anywhere DateMonday, June 3, 2013
First Use In Commerce DateMonday, June 3, 2013

Trademark Owner History

Party NameMERZ PHARMA GmbH & CO. KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFRANKFURT am MAIN D-60318
DE
Party NameMERZ PHARMA GmbH & CO. KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFRANKFURT am MAIN D-60318
DE
Party NameMERZ PHARMA GmbH & CO. KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFRANKFURT am MAIN D-60318
DE

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, January 16, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, January 16, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 18, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, October 8, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, October 21, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, October 21, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, October 21, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 9, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 8, 2013REGISTERED-PRINCIPAL REGISTER
Friday, September 6, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Thursday, September 5, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, September 3, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 29, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, July 26, 2013USE AMENDMENT FILED
Wednesday, August 28, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 26, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, July 16, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2013NOTICE OF PUBLICATION
Friday, April 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 12, 2013ASSIGNED TO LIE
Friday, March 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 21, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 20, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 20, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 21, 2012NON-FINAL ACTION MAILED
Friday, September 21, 2012NON-FINAL ACTION WRITTEN
Thursday, September 20, 2012ASSIGNED TO EXAMINER
Wednesday, June 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 7, 2012NEW APPLICATION ENTERED

Related Keywords

namenda disorders diseases conditions neurologic cerebral preparations treatment pharmaceutical